Recent data indicate that megakaryocyte/platelet alpha-granule fibrinogen is endocytosed from plasma. Because fibrinogen is the major platelet protein present in high concentrations in alpha-granules, fibrinogen uptake into alpha-granules may occur via specific receptors. In that cells of the megakaryocyte/platelet lineage contain two integrins--alpha IIb beta 3 (GP IIb-IIIa) and the vitronectin receptor (alpha v beta 3)--that can bind fibrinogen, one or both of these receptors may mediate the endocytic uptake of fibrinogen. To test this hypothesis, we examined the effect of Kistrin, an RGD-containing protein purified from the venom of Agkistrodon rhodostoma that inhibits fibrinogen binding to human platelet receptors, on endocytosis of fibrinogen by megakaryocytes and platelets. Continuous intravenous infusion of kistrin into guinea pigs (200 micrograms/h) over a 24-h period inhibited collageninduced platelet aggregation. When biotinylated fibrinogen was injected intravenously into animals receiving Kistrin, megakaryocytes failed to endocytose the labeled fibrinogen. Endocytosis of fibrinogen into platelets was also inhibited in these animals. In contrast, platelets and megakaryocytes obtained from sham-infused control animals contained the injected biotinylated fibrinogen. We conclude that, in addition to the well-known extracellular function of cell adhesion, integrins can also act as receptors that mediate endocytosis of exogenous proteins and incorporate them into regulated secretory granules.
Introduction
Investigations using the sensitive polymerase chain reaction have shown that, whereas fibrinogen is a major platelet a-granule protein, megakaryocytes, the bone marrow precursor cells from which platelets are derived, do not contain the specific mRNA for fibrinogen (1) (2) (3) . Thus, megakaryocytes do not synthesize the fibrinogen present in a-granules, but rather, acquire these proteins by endocytosis (4, 5) . Therefore, the platelet agranule appears to be a unique type ofsecretory granule, whose contents originate both by endogenous synthesis (i.e., platelet factor 4 [PF-4]1') and endocytosis ofcirculating plasma proteins (fibrinogen, immunoglobulin G, and albumin) (1, 4) . Because fibrinogen is present in higher concentrations relative to the other endocytosed plasma proteins such as albumin and IgG, it has been postulated that endocytosis of fibrinogen by megakaryocytes and platelets may be receptor mediated (4, 6, 7).
The major fibrinogen receptor on platelets, aUbf3, is present in large numbers (-50,000 receptors per platelet), and although cell type specific, belongs to a supergene family of cell surface receptors known as integrins (8) (9) (10) . In addition to aIbf3, platelets (and presumably megakaryocytes) also contain several other integrins, including vitronectin (aW3), collagen (a2 1) , fibronectin (a5fl1), and laminin (VLA-6) receptors. One of these, a'03, also binds fibrinogen (1 1, 12) , but is present in very low numbers (-50-100 per platelet) (13) .
We hypothesized that, if aIp83 and/or a'(B3 are the receptor(s) that mediate fibrinogen uptake, an antagonist of these receptors, such as kistrin, might inhibit fibrinogen endocytosis. Kistrin (Mr 7,318) belongs to a group of integrin inhibitory proteins isolated from viper venoms, known as disintegrins, that contains the arg-gly-asp (RGD) sequence, and binds with high affinity to platelet aI83 (14, 15) . Kistrin directly inhibits the interaction of purified platelet afi3 with immobilized fibrinogen -100 times more effectively than does gly-arg-glyasp-ser (14) . Furthermore, Kistrin injected into animals reversibly inhibits platelet aggregation in vivo without induction of thrombocytopenia (14) . Kistrin also binds to aB03 (16) .
The question that we have asked is whether an antagonist to platelet fibrinogen receptors aMJ63 and a'(3 can block megakaryocyte and platelet uptake of biotinylated fibrinogen in vivo. In the present study, we tested this hypothesis by infusing kistrin into guinea pigs and determining the extent ofuptake of biotinylated fibrinogen into megakaryocytes and platelets. Our results showed that kistrin blocked endocytic uptake offibrinogen into these cells, suggesting that, indeed, the receptor that mediates endocytosis of fibrinogen is an integrin.
Materials Methods
Proteins and reagents. Human fibrinogen (grade L, KabiVitrum, Stockholm, Sweden) was used in all experiments. Kistrin was prepared as previously described (14) . The antibodies used were rabbit antiguinea pig albumin (Cappel, Organon Teknika Corp., Rockville, MD), rabbit anti-human von Willebrand factor (vWf; Dako Corp., Carpinteria, CA), rabbit anti-biotin (Enzo Biochem Inc., New York), and anti-human PF-4 (a gift from Dr. Shirley Levine, San Antonio, TX). These antibodies, made against human proteins, cross-react with their guinea pig counterparts. The biotinylated goat anti-rabbit IgG secondary antibody was from Vector Labs Inc., Burlingame, CA, and the Biotinylation of kistrin. 5.0 mg of kistrin, 2.5 mg/ml in 0.15 M NaCl/O.Ol M NaPO4, pH 7.4 was incubated with biotinyl-E-amino-caproic acid N-hydroxysuccinimide ester at a final concentration of 50 ,ug/ml at 0°C for 3 h. The kistrin was then dialyzed extensively against 0.15 M NaCl/0.01 M NaPO4 (pH 7.4). Low molecular weight cutoff (mol wt 1,000)-dialysis tubing from Spectrum Medical Industries Inc., Los Angeles, CA, was used.
Determining the endocytic receptor blocking effect ofkistrin in vivo.
10 male Hartley guinea pigs, each weighing 450-500 g, were used in the experiments. Because kistrin appears to have a short in vivo half-life (14) it was administered by slow, continuous, intravenous infusion in order to maintain a sustained plasma kistrin level (thereby maintaining a continuous blockade of the receptors). All substances were administered to guinea pigs via an indwelling jugular catheter. Continuous infusions were carried out using a compact infusion pump. In experiments designed to determine the receptor-blocking effects of kistrin, animals were given 200 ,g of kistrin over 1 h by continuous intravenous infusion followed by a 250-mg bolus of biotinylated fibrinogen. The infusion of kistrin at 200 ,ug/h was then continued for 24 h. In control animals, in addition to biotinylated fibrinogen, saline was administered in similar volumes in place of kistrin. Animals were killed 24 h later, and the bone marrow and blood platelets were processed for immunohistochemical detection of biotinylated fibrinogen.
Determining thefate ofkistrin molecules bound to megakaryocytes and platelets in vivo. A second group of experiments was carried out to determine the fate of kistrin that bound to megakaryocytes and platelets. In this experiment biotinylated kistrin was infused into guinea pigs over a 4-h period. Localization of biotinylated kistrin in megakaryocytes was carried out on plastic embedded bone marrow sections at the light microscopic level. Kistrin in platelets was localized at the ultrastructural level using frozen thin section electronmicroscopy as described below.
Studies on megakaryocytes
After the animals were killed, the bone marrow was perfusion-fixed (4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4, for 4 h at 4°C), embedded in plastic (JB 4, Polysciences, Inc., Warrington, PA), and processed for immunohistochemistry as described previously (4) .
Detection ofbiotinylatedproteins in bone marrow. The biotinylated fibrinogen or kistrin was localized on plastic-embedded marrow sections by staining with streptavidin-peroxidase followed by biotinylated peroxidase.
Detection of other a-granule proteins. Localization of albumin, vWf, and PF-4 in bone marrow megakaryocytes was carried out using immunohistochemical staining techniques previously described (4), except that the biotin sites in the tissue (injected biotinylated protein) were blocked using a biotin-blocking kit before applying the primary antibodies.
Control experiments. To determine the specificity of staining for biotin, bone marrow sections were preincubated with biotin-blocking reagents. Another control consisted of staining marrow from an untreated guinea pig for the presence of biotin. Controls for immunohistochemistry included the substitution of nonimmune rabbit serum for the primary antibody.
Studies on platelets
Platelet aggregometry. Platelet aggregation was performed using a whole-blood aggregometer (model 560 VS, Chrono-Log Corp., Havertown PA) with collagen as the agonist. Blood was collected by cardiac puncture into 3.8% sodium citrate. Efficacy of kistrin in the guinea pig was determined by the amount of kistrin needed to inhibit normal guinea pig platelet aggregation in vitro. Aggregation assays were done at the termination ofthe experiments on blood drawn from animals continuously infused with Kistrin or saline (control) for 24 h.
Platelet counts. Platelet counts were done on samples obtained before kistrin treatment, 6 and 24 h after kistrin using a counter (Coulter Corp., Hialeah, FL).
Detection ofbiotinylatedfibrinogen in platelets. Blood was collected from both kistrin-treated and control animals 24 h after infusion of biotinylated fibrinogen. Platelets were harvested, washed, and solubilized in 2.0% sodium dodecyl sulfate (SDS) as previously described (4) . Solubilized platelets were electrophoresed in nonreduced SDS-5% polyacrylamide gels at 100 V. Proteins were transferred for 1 h at 100 V to 0.45-mm nitrocellulose; blocked for 30 min with 5% gelatin, then incubated with avidin-horseradish peroxidase diluted 1:500 for 1 h, and washed thrice with Tris-buffered saline (pH 7.4). The reaction was terminated with 4-chloronapthol and hydrogen peroxide.
Quantitation ofdetection threshold in Western blots. To determine the sensitivity of our Western blotting technique, a dilution series of biotinylated fibrinogen was electrophoresed in a SDS 5% polyacrylamide gel, transferred to nitrocellulose, and stained with avidin-peroxidase as described above.
Detection ofother a-granule proteins in platelets. (a) Western blotting: the effect of kistrin on two other a-granule proteins was determined using immunoblots. Rabbit antibodies against PF-4 and vWf (see above) were used for staining. (b) Radial immunodiffusion: quantitation ofplatelet a-granule albumin was performed by radioimmunodiffusion, using a commercially available immunoplate for measuring low levels ofalbumin (NANORID Albumin LL, The Binding Site Inc., San Diego CA). Although the antibody used in the assay was against human albumin, it cross-reacted with the guinea pig counterpart. Washed guinea pig platelets were prepared as for Western blots. Platelets (1 x 107) were solubilized using 1% Triton X-100 in PBS, freeze thawing, and sonication for 15 min. Three dilutions of purified guinea pig albumin (Sigma Chemical Co., St. Louis, MO) was used to obtain a standard curve, and results of the test sample were read off this graph.
Electronmicroscopic localization ofkistrin in Platelets. The injected biotinylated kistrin was localized by electron microscopy on frozen thin sections to determine if kistrin molecules that bind to platelets were endocytosed. Platelets were fixed in 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) for 2 h at 4°C. Platelets were then infiltrated overnight with 2.3 M sucrose, embedded in sucrose, frozen, and stored in liquid nitrogen till sections were cut. Biotinylated kistrin was localized using rabbit anti-biotin antibody and a 1-nm gold probe conjugated to goat anti-rabbit IgG. The small probe was then amplified using silver chloride to facilitate detection ( 17) . Controls consisted of platelets from normal guinea pigs processed and stained identically.
Results
Studies on Megakarycytes Effect of kistrin on endocytosis offibrinogen by megakaryocytes. We previously showed that when biotinylated fibrinogen is administered to guinea pigs, it is endocytosed by bone marrow megakaryocytes and incorporated into a-granules (4) . Similarly, in the present study, the injected biotinylated fibrinogen was endocytosed by bone marrow megakaryocytes in control animals (Fig. 1 a) . In addition, the presence of biotinylated fibrinogen in the bone marrow vasculature suggested that it was still circulating at the time ofdeath (Fig. 1 a) . In contrast, when biotinylated fibrinogen was injected into animals given kistrin, there was a marked diminution to complete absence of staining in bone marrow megakaryocytes (Fig. 1 b) . Quantitative analysis of these data is presented in Table I soids of kistrin-treated animals contained labeled fibrinogen comparable to controls (Fig. 1 b) . This indicated that even though the fibrinogen was circulating and available to megakaryocytes and platelets it was not endocytosed. Staining of megakaryocytes for two other a-granule proteins, vWfand PF- 
Studies on platelets
Platelet aggregation. Kistrin inhibited collagen-induced aggregation ofguinea pig platelets in vitro in a dose-dependent manner. Even at concentrations as low as 50 nM, kistrin was able to completely inhibit platelet aggregation in guinea pig whole blood (data not shown). Similarly, platelet aggregation was completely inhibited in animals receiving kistrin infusions (Fig. 2) . The petechial and ecchymotic hemorrhages observed Figure 2 . Inhibition of collagen-induced platelet aggregation in whole blood by the infusion of kistrin into a guinea pig. The platelets obtained from the control animal, which was given a saline infusion, aggregated rapidly in response to 5 484 and 694 x 103hl, which is within the reported normal range for the guinea pig (18) .
Effect ofkistrin on incorporation offibrinogen into platelets.
As shown in fig. 3 (left) , labeled fibrinogen could not be detected in platelets of kistrin-treated animals. The technique used to detect biotinylated fibrinogen in platelets was extremely sensitive (Fig. 3, right Effect ofKistrin on other a-granule proteins. We next determined whether blockage of a!IIb3 by kistrin affected endogenous a-granule proteins. Platelets from control and kistrintreated animals were analyzed by Western immunoblotting for PF-4 (Fig. 4, left) and the reduced (Mr -220,000) subunit of vWf (Fig. 4, right) . There was no detectable difference in these two endogenously synthesized proteins in controls and in animals infused with kistrin. The fact that kistrin did not alter two a-granule proteins known to be synthesized by megakaryocytes but completely inhibited the appearance ofbiotinylated fibrinogen in platelets suggests that this effect is due primarily to uptake of the latter and not to a generalized alteration of agranule proteins. Furthermore, the platelet albumin level in a guinea pig receiving kistrin was 10.1 fg per platelet, whereas that of a control animal receiving saline was 9.2 fg per platelet. Human platelets which are slightly larger than those in the guinea pig contain 14.5±4.1 fg per platelet (19) . Thus, albumin an a-granule protein derived exclusively from endocytosis also appears to be unchanged by the Kistrin infusion.
Although endogenous vWf is likely to represent most or all of that found in platelets, it is possible that a minor fraction of a-granule vWfis endocytosed from plasma via a,II33 because it binds to this receptor (20) (Fig. 4b) . The significance of this band and its absence in platelets from animals treated with kistrin is unclear.
Electronmicroscopic localization of kistrin in platelets. To determine if the kistrin that bound to the platelet endocytic receptor was internalized and incorporated into a-granules, we performed ultrastructural localization of kistrin on platelets collected after 4 h of infusion. In that an antibody against kistrin was not available to us, we labeled the kistrin with biotin and localized the biotinylated protein in platelets. Platelets contained endocytosed kistrin within a-granules and other organelles (Fig. 5) . There was marked variability in the amount and location of kistrin among platelets. Some platelets had only an occasional a-granule that contained kistrin (Fig. 5 a) . Frequently, labeling was closely associated with the granule membrane (Fig. 5 a) . Labeling was also seen on the platelet plasma membrane (Fig. 5, b and d inset) . Kistrin was sometimes observed within organelles other than typical a-granules (Fig. 5, b and c) . Multiple kistrin-containing a-granules were seen in -15% of the platelets (Fig. 5 ). Only about 60% of platelets labeled for the presence of kistrin. Because the lifespan of a guinea pig platelet appears to be about 4 d, only a small percentage of platelets would be shed from bone marrow megakaryocytes during the 4-h period of kistrin infusion. Thus, it is likely that at least some ofthe kistrin was endocytosed by circulating platelets.
Discussion
Endocytosis of biotinylated fibrinogen by megakaryocytes and platelets was prevented by the intravenous infusion of kistrin, an RGD-containing protein that inhibits fibrinogen binding to integrins. The mechanism of inhibition presumably is due to kistrin binding in vivo to megakaryocyte and platelet integrins that bind fibrinogen, preventing delivery of fibrinogen to its storage site, the a-granule. Indeed, we have been able to follow the relocation of biotinylated kistrin from its binding on the plasma membrane to the membranes surrounding a-granules after internalization. Because fibrinogen, which is 10% of the protein of a-granules (22, 23), is not synthesized by megakaryocytes (1-3) and is highly concentrated relative to its presence in plasma (7), we feel justified in concluding that it is delivered to its storage site by receptor-mediated endocytosis. Furthermore, it appears to be mediated by integrins, because endocytosis can be prevented by an integrin antagonist. Our data are in accord with observations that platelet-fibrinogen levels decrease in humans (24) and monkeys (25) after the infusion of antibodies against ajIb/33-In most cell types, proteins contained in secretory granules are endogenously synthesized and then packaged into granules (26) . In addition to endogenous proteins, a few cell types such as basophilic leukocytes (27) , mast cells, granule-containing lymphocytes (28) , salivary gland cells (29) , and megakaryocytes (30) also incorporate exogenous proteins into their granules by endocytosis; however, little is known about the mechanisms and pathways involved in the uptake and incorporation of these exogenous proteins into granules. Coated pits and vesicles containing the tracer protein horseradish peroxidase, as well as fibrinogen attached to colloidal gold, have been reported in platelets and megakaryocytes (30, 31) . Recently, it was shown that coated pit-mediated internalization ofthe LDL receptor requires the presence of the consensus sequence NPXY (where X stands for any amino acid) in the cytoplasmic tail (32) . It is interesting that the NPXY sequence is also found in cytoplasmic domains of some integrin subunits, including platelet GP Illa (32) . Although receptor-mediated endocytosis of many ligands is well characterized, their destination is usually the endosomal or lysosomal compartments (33-35). The fibrinogen endocytosed by megakaryocytes is incorporated into a-granules and the platelets are able to secrete the intact fibrinogen molecule upon stimulation (4, 36) . Thus, the integrin-mediated endocytosis offibrinogen in megakaryocytes and platelets and its incorporation into a secretory granule may involve a previously unrecognized pathway. The present data show that even when a nonphysiologic protein such as kistrin binds to this receptor, it is targeted to the a-granule.
Kistrin has been shown to bind a1I/3 and inhibit fibrinogen binding (14) . Kistrin of platelet fibrinogen (37) , which has also been reported in a group ofthrombasthenics who lack a1IId3 but who have normal or increased amounts of av133 (13); (b) fibrinogen y' variant, which binds weakly to aIIb13, is not found in platelet a-granules even though it constitutes 10% of normal plasma fibrinogen (38) ; (c) the platelets of Paris I type dysfibrinogenemia patients do not contain abnormal fibrinogen, although 50% of the fibrinogen molecules in plasma have the defect (39) . Binding of the abnormal Paris I fibrinogen to aHIIb/3 is impaired (40); (d) compared to ahlIb/3 (50,000 copies per platelet) the a'v33 (100 copies per platelet) is a relatively minor platelet integrin. These observations, when taken together with the present experimental data, strongly suggest that the primary receptor that mediates fibrinogen endocytosis is aIIbf3-A variety ofligands, including fibrinogen, vWf, fibronectin, and thrombospondin, bind to aIIb/3 on stimulated platelets (41) . The recognition sequence common to these proteins is RGD. The fibrinogen molecule contains two RGD sequences both on the Aa chain and an additional aIIb/3 binding site located at the carboxyl-terminus ofthe oy chain, which includes 12 amino acids, but does not contain the RGD sequence (42) . This dodecapeptide and RGD containing peptides compete with each other for binding to aIIbA3 (43 (55, 56) . Specific binding of purified invasin to f1 chain paired to a chains 3, 4, 5, or 6 (57) suggests that attachment and entry into cells ofbacteria expressing invasin requires these integrins. Other examples of integrin-mediated phagocytic uptake of microbes include Legionella pneumophilia (58) , Bordetella pertussis (59) , and the protozoan Leishmania (60) .
There is little information on endocytosis and recycling of either occupied or free integrins. It has been shown that the fibronectin receptor expressed in CHO cells is constitutively endocytosed and recycles with a time course of 80 minutes (61, 62) . The internalization of this integrin appears to be independent of receptor occupancy (62) . The actual mechanisms involved in endocytosis of the fibronectin receptor, or its physiologic significance, however, have not been determined. Particularly relevant to the present study is the demonstration of an actively cycling pool of ajIb33 in platelets (63, 64) and its presence on the a-granule membrane (65, 66) . However, the intragranular storage pattern determined by immunoelectron microscopy shows fibrinogen to be randomly distributed in the matrix of a-granules except the nucleoid (67, 68) . This suggests that at least some ofthe fibrinogen molecules within a-granules may dissociate from their membrane-bound receptor. The endocytosed kistrin that was incorporated into a-granules showed a similar distribution, suggesting that some of the kistrin molecules may have dissociated from their receptor/s after reaching the a-granule.
The functional role of platelet integrins has been exclusively associated with their well-established cell-cell and cellmatrix interactions. Thus, the sole function attributed to integrins such as a!IIbf3 is their role in platelet aggregation during formation ofthe hemostatic plug. This study draws attention to a previously unrecognized function of integrins that come into play during the development of cells of the platelet lineage, namely receptor-mediated endocytosis and storage of a major granule protein. It is possible that integrin-mediated endocytosis of exogenous proteins may in fact be a widely prevelant physiologic phenomenon that has not been previously recognized.
